Refacto AF

Factor VIII, recombinant · Pfizer

Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for Refacto AF, covering 2008-04-22 to 2025-03-05. Get the full timeline:

Most recent: EMA Authorised: ReFacto AF (moroctocog alfa) — Pfizer Europe MA EEIG